| PARK3 |
|
Parkinson disease 3 (autosomal dominant, Lewy body)
|
|
|
0.821 |
0.038 |
| SYT17 |
Q9BSW7
|
synaptotagmin 17
|
Transporter
|
1.1E-05 |
1.000 |
0.038 |
| USP40 |
Q9NVE5
|
ubiquitin specific peptidase 40
|
Enzyme
|
1.2E-25 |
0.931 |
0.038 |
| TPTE2P6 |
|
transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 6
|
|
|
0.931 |
0.038 |
| TMC3-AS1 |
|
TMC3 antisense RNA 1
|
|
|
1.000 |
0.038 |
| PARK10 |
|
Parkinson disease 10 (susceptibility)
|
|
|
0.890 |
0.038 |
| CDCP2 |
Q5VXM1
|
CUB domain containing protein 2
|
Enzyme
|
9.5E-11 |
1.000 |
0.038 |
| TYW1B |
Q6NUM6
|
tRNA-yW synthesizing protein 1 homolog B
|
|
5.4E-20 |
1.000 |
0.038 |
| VPS29 |
Q9UBQ0
|
VPS29 retromer complex component
|
Transporter
|
0.75 |
0.890 |
0.038 |
| MIDN |
Q504T8
|
midnolin
|
|
0.18 |
0.890 |
0.038 |
| PRSS53 |
Q2L4Q9
|
serine protease 53
|
|
9.4E-17 |
1.000 |
0.038 |
| DPY19L2P3 |
|
DPY19L2 pseudogene 3
|
|
|
1.000 |
0.038 |
| SNCA-AS1 |
|
SNCA antisense RNA 1
|
|
|
1.000 |
0.038 |
| PARK12 |
|
Parkinson disease 12 (susceptibility)
|
|
|
1.000 |
0.038 |
| FAM47E |
Q6ZV65
|
family with sequence similarity 47 member E
|
|
1.7E-03 |
1.000 |
0.038 |
| MIR3143 |
|
microRNA 3143
|
|
|
1.000 |
0.038 |
| FAM47E-STBD1 |
Q6ZV65
|
FAM47E-STBD1 readthrough
|
|
7.7E-12 |
1.000 |
0.038 |
| UCHL1-AS1 |
|
UCHL1 antisense RNA 1 (head to head)
|
|
|
1.000 |
0.038 |
| LOC101928100 |
|
uncharacterized LOC101928100
|
|
|
1.000 |
0.038 |
| KLHDC1 |
Q8N7A1
|
kelch domain containing 1
|
|
4.5E-08 |
1.000 |
0.038 |
| TCEANC2 |
Q96MN5
|
transcription elongation factor A N-terminal and central domain containing 2
|
Nucleic acid binding
|
2.8E-07 |
1.000 |
0.038 |
| SPTSSB |
Q8NFR3
|
serine palmitoyltransferase small subunit B
|
|
8.7E-04 |
1.000 |
0.038 |
| SEC22A |
Q96IW7
|
SEC22 homolog A, vesicle trafficking protein
|
|
1.4E-06 |
1.000 |
0.038 |
| RPA2P1 |
|
replication protein A2 pseudogene 1
|
|
|
1.000 |
0.038 |
| DRAXIN |
Q8NBI3
|
dorsal inhibitory axon guidance protein
|
|
1.9E-10 |
1.000 |
0.038 |